Home › Major Depressive Disorder › Nevada › Las Vegas
Major Depressive Disorder clinical trials in Las Vegas, NV
13 studies for Major Depressive Disorder are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RecruitingPhase 2
- Redbird Research LLC, Las Vegas
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Redbird Research, LLC, Las Vegas
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RecruitingPhase 3
- Redbird Research, Las Vegas
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Vector Clinical Trials, Las Vegas
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecruitingPhase 3
- Vector Clinical Trials, Las Vegas
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Redbird Research, Las Vegas
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecruitingPhase 3
- Vanda Investigational Site, Las Vegas
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RecruitingPhase 2
- Draig Clinical Site, Las Vegas
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecruitingPhase 3
- IMA Clinical Research Las Vegas, Las Vegas
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RecruitingPhase 3
- Clinical Research Site, Las Vegas
- Clinical Research Site, Las Vegas
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RecruitingPhase 2
- Redbird Research /ID# 277485, Las Vegas
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 344, Las Vegas
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Las Vegas
Major Depressive Disorder trials in other cities
- New York City, NY36 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Chicago, IL17 studies
- Tampa, FL17 studies
- San Diego, CA16 studies
- Houston, TX16 studies
- Little Rock, AR14 studies
- Austin, TX13 studies
Other studies in Las Vegas
- Obesity27 studies
- Overweight23 studies
- Type 2 Diabetes18 studies
- Non-Small Cell Lung Cancer13 studies
- Breast Cancer10 studies
- Alzheimer's Disease8 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Cancer (all types)8 studies
- Schizophrenia7 studies
- Atherosclerosis7 studies
- Steatotic Liver Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.